-
Cancer drugs: 4 updates to know
As pharmaceutical innovation for oncology care continues to grow, here are four updates to know: -
Memorial Sloan Kettering names 2 new oncology chiefs
Memorial Sloan Kettering Cancer Center in New York City has appointed two oncology chiefs. -
American Cancer Society CEO to exit 2 roles
Karen Knudsen, PhD, CEO of both the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network, will transition from the organizations. -
Moffitt, AstraZeneca partner on cell therapy development
Tampa, Fla.-based Moffitt Cancer Center and drugmaker AstraZeneca are collaborating to accelerate the development of CAR-T cell and T cell receptor therapies. -
Family members' health can suffer when relative has cancer: Study
Individuals are at an increased risk of cardiovascular disease and psychological illness after a family member is diagnosed with cancer, according to a study published Sept. 9 in Cancer. -
MD Anderson, Rice partner on research to improve cancer care operations
University of Texas MD Anderson Cancer Center and Rice University, both based in Houston, have partnered to launch a new operational research initiative aimed at improving cancer care operations with data. -
MD Anderson surgeons employ noninvasive liver cancer treatment
Surgeons at the Camden, N.J.-based MD Anderson Cancer Center at Cooper employed noninvasive, histotripsy technology for the treatment of liver cancer, becoming one of 20 cancer centers in the world to offer the treatment. -
Memorial Sloan Kettering identifies new lung cancer
A team from Memorial Sloan Kettering Cancer Center in New York City identified a new, rare form of small cell lung cancer, found primarily in patients who have no history of smoking. -
Centering on the patient will help ease uncertainties with low-risk cancers
With rising cancer rates among younger generations, education remains paramount in our efforts to catch cancer at an earlier, more treatable stage. -
Northern Arizona Healthcare partners with City of Hope
Flagstaff-based Northern Arizona Healthcare has partnered with Phoenix-based City of Hope to offer advanced treatment options and expertise to NAH patients with complex or rare types of cancer closer to home. -
ASCO urges CMS to ensure CAR T-cell therapy access
The American Society of Clinical Oncology has publicly urged CMS to ensure patient access to CAR T-cell therapy in response to the agency's proposed 2025 Hospital Outpatient Prospective Payment System plan. -
When clinicians become cancer patients
More people younger than 50 are getting cancer, and clinicians are not immune to this trend. -
Northwell cancer institute names new medical director
Abhisek Swaika, MD, has been named the medical director of the Northwell Health Cancer Institute at Rego Park in New York City. -
Mayo Clinic snags $50M gift
Rochester, Minn.-based Mayo Clinic received a $50 million gift to expand access to cancer care and clinical trials. -
Undiagnosed cancer persisted past pandemic's 1st year: 150,000 cases missed
Cancer continued to be underdiagnosed after the first year of the COVID-19 pandemic, according to a study published Sept. 6 in JAMA Network Open. -
'Patients are going to ask for it': Inside Ochsner's pharmacogenomic testing program
New Orleans-based Ochsner Health was met with some uncertainty when it launched its pharmacogenomic program in March 2022 and became one of the first health systems to standardize genomic testing. -
The path to 100% nurse satisfaction: A look at Lee Health's success with balanced patient assignments
When healthcare staffing shortages strain resources and limit care access, both clinical staff and patients feel the pain. -
National Cancer Institute proposes $11B budget for 2026
The National Cancer Institute has proposed a budget of more than $11 billion for the 2026 fiscal year. -
Mayo Clinic researchers find new melanoma risk factor
Individuals with monoclonal B-cell lymphocytosis may also have an increased risk of developing melanoma, according to a study published Sept. 4 in the Journal of Clinical Oncology. -
Mass General Brigham revamps cancer care model
Boston-based Mass General Brigham Cancer Center has unveiled plans for a more integrative cancer care model.
Page 3 of 50